Notice: This company has been marked as potentially delisted and may not be actively trading. Renalytix (RNLX) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestTrends Renalytix Short Interest DataRenalytix (RNLX) has a short interest of 378,900 shares. This marks a 280.42% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 1.45 million shares to cover all short positions.Current Short Interest378,900 sharesPrevious Short Interest99,600 sharesChange Vs. Previous Month+280.42%Dollar Volume Sold Short$110,525.13Short Interest Ratio0.2 Days to CoverLast Record DateSeptember 15, 2024Outstanding Shares82,960,000 sharesPercentage of Shares Shorted0.46%Today's Trading Volume934,400 sharesAverage Trading Volume1,451,440 sharesToday's Volume Vs. Average64% Short Selling Renalytix? Sign up to receive the latest short interest report for Renalytix and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRNLX Short Interest Over TimeRNLX Days to Cover Over TimeRNLX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Renalytix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/2024378,900 shares $110,525.13 +280.4%N/A0.2 $0.29 8/31/202499,600 shares $31,274.40 -45.6%N/A0 $0.31 8/15/2024183,000 shares $67,893.00 -65.1%N/A0.1 $0.37 7/31/2024524,600 shares $236,070.00 -82.8%N/A0.3 $0.45 7/15/20243,050,000 shares $1.01 million +941.3%N/A1.7 $0.33 6/30/2024292,900 shares $67,659.90 +23.8%N/A1 $0.23 Get the Latest News and Ratings for RNLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. 6/15/2024236,600 shares $120,169.14 -49.1%N/A0.9 $0.51 5/31/2024464,900 shares $192,840.52 +4.1%N/A1.7 $0.41 5/15/2024446,600 shares $253,222.20 -28.8%N/A0.6 $0.57 4/30/2024627,400 shares $435,352.86 -6.9%N/A0.3 $0.69 4/15/2024673,700 shares $567,659.62 -15.3%N/A0.4 $0.84 3/31/2024795,200 shares $683,872.00 -11.1%N/A0.4 $0.86 3/15/2024894,600 shares $769,356.00 +78.7%N/A0.5 $0.86 2/29/2024500,600 shares $585,702.00 -60.6%N/A0.3 $1.17 2/15/20241,270,000 shares $997,331.00 +111.0%N/A1 $0.79 1/31/2024601,800 shares $190,650.24 -10.5%N/A2.3 $0.32 1/15/2024672,200 shares $215,104.00 +145.3%N/A3.3 $0.32 12/31/2023274,000 shares $106,860.00 +350.7%N/A2.1 $0.39 12/15/202360,800 shares $22,204.16 -68.9%N/A0.5 $0.37 11/30/2023195,500 shares $92,862.50 -11.5%N/A1.9 $0.48 11/15/2023221,000 shares $130,611.00 -36.5%N/A2.3 $0.59 10/31/2023347,800 shares $361,712.00 +65.6%N/A4.4 $1.04 10/15/2023210,000 shares $243,600.00 +32.4%N/A2.7 $1.16 9/30/2023158,600 shares $253,760.00 -69.2%N/A1.7 $1.60 9/15/2023514,700 shares $1.09 million +4.8%N/A0.8 $2.11 8/31/2023491,000 shares $1.42 million +10.2%N/A0.8 $2.90 8/15/2023445,700 shares $1.14 million -3.8%N/A0.7 $2.55 7/31/2023463,400 shares $1.34 million -40.4%N/A0.7 $2.90 7/15/2023777,400 shares $2.92 million +123.2%N/A1.2 $3.76 6/30/2023348,300 shares $1.02 million -6.5%N/A0.6 $2.92 6/15/2023372,400 shares $871,416.00 -3.3%N/A8.1 $2.34 5/31/2023385,200 shares $943,740.00 +44.9%N/A8.3 $2.45 5/15/2023265,900 shares $582,321.00 -20.0%N/A6.6 $2.19 4/30/2023332,500 shares $788,025.00 +7.7%N/A7.5 $2.37 4/15/2023308,600 shares $765,328.00 +52.6%N/A6.2 $2.48 3/31/2023202,300 shares $489,566.00 +43.6%N/A4.1 $2.42 3/15/2023140,900 shares $324,070.00 +17.9%N/A2.5 $2.30 2/28/2023119,500 shares $423,902.35 -42.5%N/A2.3 $3.55 2/15/2023207,900 shares $685,924.47 -32.3%N/A3.7 $3.30 1/31/2023307,200 shares $915,456.00 -17.6%N/A4.8 $2.98Did You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. 1/15/2023372,900 shares $976,998.00 +0.7%N/A4.1 $2.62 12/30/2022370,400 shares $692,648.00 -8.6%N/A3.8 $1.87 12/15/2022405,300 shares $656,586.00 -7.8%N/A4.1 $1.62 11/30/2022439,700 shares $892,591.00 +6.1%N/A4 $2.03 11/15/2022414,300 shares $592,449.00 -39.7%N/A3.6 $1.43 10/31/2022687,300 shares $1.34 million -3.0%N/A6 $1.95 10/15/2022708,800 shares $886,567.04 +5.6%N/A6.6 $1.25 9/30/2022671,500 shares $859,520.00 -19.7%N/A7.7 $1.28 9/15/2022836,600 shares $1.24 million -8.8%N/A7.1 $1.48 8/31/2022917,200 shares $1.91 million +4.2%N/A8.4 $2.08 8/15/2022880,400 shares $2.25 million +6.3%N/A7.9 $2.55 7/31/2022828,000 shares $2.05 million +8.7%N/A7 $2.48 7/15/2022761,800 shares $2.02 million 0.0%N/A6.7 $2.65 6/30/2022762,100 shares $1.87 million -1.3%N/A6.7 $2.45 6/15/2022771,900 shares $3.32 million +9.2%N/A7.5 $4.30 5/31/2022706,800 shares $2.78 million -12.9%N/A6.3 $3.94 5/15/2022811,200 shares $3.59 million +9.7%N/A7.1 $4.43 4/30/2022739,600 shares $3.75 million +1.4%N/A6.6 $5.07 4/15/2022729,200 shares $4.26 million +8.5%N/A6.1 $5.84 3/31/2022671,900 shares $4.65 million No ChangeN/A5.4 $6.92 3/15/2022671,900 shares $4.25 million +15.8%N/A5.5 $6.33 2/28/2022580,300 shares $5.38 million +1.2%N/A4.6 $9.27 2/15/2022573,200 shares $6.28 million +0.3%N/A4.8 $10.95 1/31/2022571,600 shares $7.23 million -14.5%N/A4.8 $12.65 1/15/2022668,800 shares $10.29 million +26.0%N/A6 $15.38 12/31/2021530,800 shares $8.44 million +5.2%N/A5.1 $15.90 12/15/2021504,400 shares $7.55 million -0.1%N/A5.1 $14.96 11/30/2021505,100 shares $9.34 million -0.8%N/A5.1 $18.50 11/15/2021509,300 shares $11.17 million -0.9%N/A5.4 $21.94 10/29/2021513,700 shares $12.78 million +15.5%N/A5.1 $24.87 10/15/2021444,700 shares $10.97 million -9.6%N/A4.4 $24.66 9/30/2021491,900 shares $9.86 million +45.3%N/A5.1 $20.05 9/15/2021338,500 shares $6.06 million +20.7%N/A3.4 $17.91 8/31/2021280,500 shares $7.83 million -27.5%N/A3.1 $27.92 8/13/2021387,100 shares $10.78 million -18.1%N/A4.4 $27.84 7/30/2021472,600 shares $14.20 million +0.3%N/A6 $30.05 7/15/2021471,000 shares $12.54 million +7.5%N/A5.5 $26.62 6/30/2021438,300 shares $13.53 million -11.3%N/A4.3 $30.86 6/15/2021494,100 shares $16.31 million -1.5%N/A4.8 $33.00 5/28/2021501,500 shares $16.53 million +2.6%N/A4.5 $32.96 5/14/2021488,700 shares $14.03 million +11.1%N/A3.6 $28.70 4/30/2021439,700 shares $13.09 million +11.7%N/A3.3 $29.78 4/15/2021393,600 shares $10.24 million +11.8%N/A2.7 $26.02 3/31/2021352,100 shares $8.98 million +14.1%N/A2.6 $25.50 3/15/2021308,600 shares $9.57 million +243.7%N/A2.3 $31.01 2/26/202189,800 shares $2.09 million -70.5%N/A0.8 $23.30 2/12/2021304,100 shares $7.92 million +225.9%N/A3 $26.03 1/29/202193,300 shares $2.36 million -69.4%N/A1 $25.33 1/15/2021305,200 shares $6.81 million No ChangeN/A3.7 $22.32 RNLX Short Interest - Frequently Asked Questions What is Renalytix's current short interest? Short interest is the volume of Renalytix shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 378,900 shares of RNLX short. Learn More on Renalytix's current short interest. Is Renalytix's short interest increasing or decreasing? Renalytix saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 378,900 shares, an increase of 280.4% from the previous total of 99,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Renalytix's short interest compare to its competitors? Here is how the short interest of companies in the industry of "healthcare" compare to Renalytix: P3 Health Partners Inc. (0.90%), Enzo Biochem, Inc. (1.16%), Concord Medical Services Holdings Limited (0.16%), The Oncology Institute, Inc. (3.37%), Psychemedics Co. (1.25%), BioRestorative Therapies, Inc. (1.32%), OpGen, Inc. (0.19%), Kindly MD, Inc. (10.74%), Ontrak, Inc. (1.26%), Mangoceuticals, Inc. (9.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short Renalytix stock? Short selling RNLX is an investing strategy that aims to generate trading profit from Renalytix as its price is falling. RNLX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Renalytix? A short squeeze for Renalytix occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RNLX, which in turn drives the price of the stock up even further. How often is Renalytix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNLX, twice per month. The most recent reporting period available is September, 15 2024. More Short Interest Resources from MarketBeat Related Companies P3 Health Partners Short Squeeze Enzo Biochem Short Squeeze Concord Medical Services Short Squeeze Oncology Institute Short Squeeze Psychemedics Short Squeeze BioRestorative Therapies Short Squeeze OpGen Short Squeeze Kindly MD Short Squeeze Ontrak Short Squeeze Mangoceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RNLX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renalytix Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Renalytix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNLX Stock Alerts